AI assistant
Sagility Limited Investor Presentation 2026
60164_rns_2026-05-12_66f2dc1e-3c4f-47f1-a138-106b65aad2b9.pdf
Investor Presentation
Open in viewerOpens in your device viewer
sagility
Date: May 12, 2026
To,
The Manager
Listing Department
National Stock Exchange of India Limited (NSE)
Exchange Plaza, 5th Floor
Plot No. C/1, G-Block
Bandra-Kurla Complex
Bandra (E), Mumbai - 400 051
Symbol: SAGILITY
The Manager
Listing Department
BSE Limited (BSE)
Phiroze Jeejeebhoy Towers
Dalal Street
Mumbai - 400 001
Scrip Code:544282
Dear Sir/Ma’am,
Sub: Submission of Revised Investor Presentation to be made to investors on May 12, 2026, pursuant to Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Please find enclosed the revised presentation to be made to investors on the financial results of Sagility Limited for the quarter and year ended March 31, 2026, during the meeting scheduled today, i.e., Tuesday, May 12, 2026, at 7:30 p.m. (IST).
The details are also being made available on the Company’s website https://sagility.com/
This is for your information and record.
Thanking You,
For Sagility Limited
SATISHKUMAR
SAKHARAYAPATTANA
SEETHARAMAIAH
Digitally signed by SATISHKUMAR
SAKHARAYAPATTANA
SEETHARAMAIAH
Date: 2026.05.12 18:57:03 +05'30'
Satishkumar Sakharayapattana Seetharamaiah
Company Secretary & Compliance Officer
M. No. A16008
Encl: a/a
Sagility Limited
(Formerly Sagility India Limited, earlier Sagility India Private Limited)
Registered Office - No. 23 & 24, AMR Tech Park, Building 2A, First Floor Hongasandara Village, Off Hosur
Road, Bommanahalli, Bengaluru – 560068, Karnataka, India
Corporate Identification Number: L72900KA2021PLC150054
Tel. No.: 080-71251500, E-mail: [email protected], Website: www.sagility.com
sagility
Investor Deck – Q4 FY26
May 12, 2026
sagility
Safe Harbor
Certain statements in this release concerning Sagility's future growth prospects may be seen as forward-looking statements, which involve a number of risks and uncertainties that could cause the actuals to differ materially from such statements. Sagility does not undertake to update any such statement that may have been made from time to time by or on behalf of the company.
sagility
Performance Highlights
| Revenue | Adjusted EBITDA | Adjusted PAT |
|---|---|---|
| ₹ 20,243 | ||
| Million | ₹ 5,036 | |
| Million | ₹ 3,069 | |
| Million | ||
| YoY growth | ||
| 29.1% | ||
| 22.2% in CC | Margin % | |
| 24.9% | Margin % | |
| 15.2% | ||
| YoY Growth | ||
| (Excl. Broadpath) | ||
| 25.8% | ||
| 19.4% in CC | YoY growth % | |
| 20.6% | YoY growth % | |
| 28.0% | ||
| Insights | Freight | Loss |
| --- | --- | --- |
| 25.8% Y-o-Y organic growth in FY26, driven by expansion within existing clients and rising contribution from FY26 new client wins | 25.8% Y-o-Y organic growth in FY26, driven by expansion within existing clients and rising contribution from FY26 new client wins | 25.8% Y-o-Y organic growth in FY26 |
| ▶ $30.7M (potential steady state ACV) of new business & expansion won in Q4 FY26 | ||
| ▶ Expansion and new SOWs from 18 existing clients and 2 FY26 new logos in Q4 FY26 | ||
| ▶ 5 new clients onboarded in Q4 (total 17 in FY26) | ▶ $30.7M (potential steady state ACV) of new business & expansion won in Q4 FY26 | |
| ▶ Expansion and new SOWs from 18 existing clients and 2 FY26 new logos in Q4 FY26 | ||
| ▶ 5 new clients onboarded in Q4 (total 17 in FY26) | ||
| Sagility is advancing AI orchestration through SmarTec and Synchrony to drive smarter, end-to-end operations and measurable outcomes | Sagility is advancing AI orchestration through SmarTec and Synchrony to drive smarter, end-to-end operations and measurable outcomes | |
| Sagility's brand evolution positions it as a Tech & AI-led operations partner focused on delivering measurable outcomes | Sagility's brand evolution positions it as a Tech & AI-led operations partner focused on delivering measurable outcomes |
Final dividend of ₹0.1 per share
Rewards & Recognitions
- Leader Healthcare Payer Agility and Innovation 2026 NEAT NelsonHall
- Leader Healthcare Payer Intelligent Operations PEAK Matrix® Assessment 2026 Everest
- Leader in Generative AI services by ISG
- Sagility SmarTec Nurse Assist was the Winner of Augmented Intelligence award by Business Intelligence Group
KPIs
sagility
| Q4 FY26 | Q3 FY26 | Q4 FY25 | YoY% | |
|---|---|---|---|---|
| Revenue from Operation (in ₹M) | 20,243 | 19,712 | 15,685 | 29.1% |
| Revenue by Vertical Split | ||||
| By Payer % | 90.8% | 90.4% | 89.7% | |
| By Provider % | 9.2% | 9.6% | 10.3% | |
| Growth in revenue from operation (%) | 29.1% | 35.7% | 22.2% | |
| Adjusted EBITDA (in ₹M)* | 5,036 | 5,125 | 4,176 | 20.6% |
| Adjusted EBITDA % | 24.9% | 26.0% | 26.6% | |
| Adjusted PAT (in ₹M)** | 3,069 | 3,229 | 2,398 | 28.0% |
| Adjusted PAT % | 15.2% | 16.4% | 15.3% | |
| Total Number of Employees | 46,860 | 48,522 | 39,409 | 18.9% |
| Voluntary attrition rate^ (%) | 38.1% | 22.8% | 32.5% |
Note: Adjusted EBITDA represents EBITDA adjusted for earnouts payable under acquisition agreements (DCI, BirchAI & BroadPath), share-based payment awards and exclude other income (including forex gain/loss).
Adjusted PAT reflects EBITDA adjustments and adjustments for amortisation of intangible assets arising from the carve-out of the healthcare business from HGS, as well as the statutory impact of the new labor codes in India, net of tax
^Voluntary attrition is calculated for employees with tenure exceeding 90 days and presented on an annualized basis, derived from voluntary exits during the respective quarter
| FY26 | FY25 | YoY% |
|---|---|---|
| 71,929 | 55,699 | 29.1% |
| 89.7% | 89.4% | |
| 10.3% | 10.6% | |
| 29.1% | 17.2% | |
| 18,200 | 14,685 | 23.9% |
| 25.3% | 26.4% | |
| 11,306 | 8,107 | 39.5% |
| 15.7% | 14.6% | |
| 46,860 | 39,409 | 18.9% |
| 29.4% | 27.5% |
\star
sagility
Annual KPIs
| FY26 | FY25 | FY24 | FY23 | |
|---|---|---|---|---|
| Numbers of Client group | ||||
| Active | 82 | 75 | 44 | 35 |
| Number of new client addition (Gross) | 17 | 38 | 13 | 7 |
| Delivery Sites | ||||
| Number of delivery sites | 31 | 33 | 30 | 27 |
| New site addition (Gross) | 4 | 10 | 4 | 2 |
| Client groups contribution to revenues* | ||||
| Top 3 client % | 59.9% | 66.2% | 68.3% | 72.4% |
| Top 5 client % | 70.4% | 77.9% | 79.2% | 80.6% |
| Top 10 client % | 83.9% | 90.5% | 91.4% | 90.7% |
| Number of Million-dollar client groups** | ||||
| Number of clients contributing more than US$20 million | 9 | 7 | 5 | 4 |
| Number of clients contributing to US$5 - US$20 million | 7 | 6 | 7 | 7 |
| Number of clients contributing to US$1 - US$5 million | 21 | 12 | 12 | 12 |
| Number of clients contributing less than US$1 million | 45 | 50 | 20 | 12 |
Top 3 client CAGR of $9.1\%$ (in CC) over FY23 to FY26.
Overall CAGR of $16.2\%$ (in CC) over FY23 to FY26.
**Client groups comprise client entities together with their affiliates.
*Client group represent top client based on last twelve months revenue for the respective period
Business Updates
sagility
Regulatory Society of America
Recent Market Trends – Q4
| Market Trends | Impact on Payer | Implications for Sagility |
|---|---|---|
| CMS finalized Medicare Advantage Rates at 2.48% Y-o-Y increase | This presents payers with a little more favorable reimbursement environment vs the near-flat proposal initially expected that eases some pressure on margins. Profitability pressures still continue though. | Proposals that focus on cost takeout in administrative functions and improving STARs ratings resonate with payers who are still encountering increased medical utilization. |
| House Passes Bill to extend/enhance ACA premium subsidies | With coverage remaining affordable, Marketplace enrollment is expected to stay stable, supporting a favorable insured member risk mix heading into 2027 | |
| Payers are likely to sustain operational spend across enrollment, billing, and engagement services. | While Sagility currently has low exposure to the ACA market, this strengthens the case for automation & AI led models to manage service complexity and cost pressures. | |
| State Medicaid expansion incentives have ended, effective 2026 | The expiration of federal Medicaid expansion incentives removes a key catalyst for incremental state-level expansion activity, likely moderating future Medicaid membership growth. | While Sagility has low exposure to the Medicaid market, cost optimization is likely to become a greater strategic priority for these plans, further accelerating adoption of automation-led operating models and efficiency-focused outsourcing initiatives. |
| CMS launched the Advancing Chronic Care with Effective, Scalable Solutions (ACCESS) model | CMS' push to outcome based chronic care management with tech-enabled care central to the model | While this is focused on Original Medicare, it aligns closely with our strategic focus on helping MA plans with analytics-led care management, and technology-enabled member engagement and support services. |
Brand Promise
Sagility delivers value in healthcare operations with deep domain expertise, technology & AI-led transformation, and trusted collaboration.
| 80+
Healthcare Clients | 18
Average Client Tenure in Years |
| --- | --- |
| 37
AI Use-Cases Deployed | 4400+
Clinicians and Technology Experts |
| 25+
Years exclusively in healthcare | >50
NPS/CSAT |
sagility
80
Executive Client Attendees
Client Endorsed Solutioning
Co-creating outcome-driven healthcare solutions with our clients - combining their operational insight with Sagility's innovation to accelerate measurable impact.
Innovation Forum
1
Reducing Medical Costs – Clinical Context to Action Solution
2 Member Pain Index
3 Reducing Payer/Provider Friction
Key Client Themes
- AI is rapidly reshaping operating models to lower medical costs while improving member and patient outcomes.
- AI deployment decisions are becoming increasing collaborative with business operations and technology leaders jointly shaping the path forward.
- The key to execution is through a robust partnership ecosystem resulting in outcomes-based decisioning versus traditional models.
Financial Highlights
sagility
Financial Highlights
sagility
Q4 FY26
| Revenue | Adjusted EBITDA | Adjusted PAT | OCF |
|---|---|---|---|
| ₹ 20,243 million | ₹ 5,036 Million | ₹ 3,069 Million | ₹ 5,327 Million |
| YoY growth 29.1% | |||
| 22.2% at Constant Currency | Margin % 24.9% | Margin % 15.2% | Conversion % 104.6% |
| YoY Growth (Excl. Broadpath) 25.8% | |||
| 19.4% at Constant Currency | YoY growth % 20.6% | YoY growth % 28.0% | DSO 87 days |
FY26
| Revenue | Adjusted EBITDA | Adjusted PAT | OCF |
|---|---|---|---|
| ₹ 71,929 million | ₹ 18,200 Million | ₹ 11,306 Million | ₹ 12,030 million |
| YoY growth 29.1% | |||
| 23.6% at Constant Currency | Margin % 25.3% | Margin % 15.7% | Conversion % 64.7% |
| YoY Growth (Excl. Broadpath) 20.1% | |||
| 15.0% at Constant Currency | YoY growth % 23.9% | YoY growth % 39.5% | DSO 87 days |
FY26 marked by strong top-line growth, margin resilience, and healthy operating cash flow
sagility
Quarterly Seasonality
Our Revenues exhibit seasonality. Growth in Q3 & Q4 is impacted by Open Enrollment volumes
sagility
Long Term Financial performance snapshot
*Adjusted EBITDA represents EBITDA adjusted for earnouts payable under the acquisition agreements (DCI, BirchAI & BroadPath), share-based payment awards and exclude other income (including forex gain/loss).
sagility
Other Financial Indicators
Adjusted EPS (in ₹)
Adjusted ROCE %
Cash Conversion (%)
Net Debt
OCF conversion in FY26 @ 64.7% driven by higher Non-cash (unrealized) forex Gains, lower non-cash expenses and higher tax payouts
Adjusted EPS is Adjusted PAT divided by weighted average number of equity shares
Adjusted ROCE is Adjusted PAT plus Interest cost divided by capital employed (Assets excluding goodwill and intangibles assets less current liabilities)
Net Debt is Borrowing plus lease liabilities less Cash and Cash equivalent including investment in Mutual Fund and Deposits . Borrowing doesn't include accrued interest
sagility
Q4 FY26 Consolidated Profit and Loss
Amt in ₹ M
| Particulars | Q4 FY26 | Q3 FY26 | Q4 FY25 | YoY% | QoQ% |
|---|---|---|---|---|---|
| Revenue from Operation | 20,243 | 19,712 | 15,685 | 29.1% | 2.7% |
| Employee benefits expense* | 12,580 | 12,211 | 9,429 | ||
| Other expenses^ | 2,627 | 2,376 | 2,079 | ||
| Adjusted EBITDA** | 5,036 | 5,125 | 4,176 | 20.6% | -1.7% |
| Adjusted EBITDA % | 24.9% | 26.0% | 26.6% | ||
| Adjustments: | |||||
| M&A Earnouts | 150 | 42 | 207 | ||
| SAR (stock appreciation right) – Non Cash | 39 | -61 | 104 | ||
| Other Income^^ | 82 | 84 | 101 | ||
| Forex Gain / (Loss) | 166 | -33 | -135 | ||
| Reported EBITDA | 5,094 | 5,195 | 3,832 | 33.0% | -1.9% |
| Finance costs | 221 | 247 | 298 | ||
| Depreciation and amortisation | 1,242 | 1,235 | 1,143 | ||
| Profit before Exceptional Items | 3,632 | 3,713 | 2,390 | 52.0% | -2.2% |
| Statutory impact of new labor code in India | 328 | ||||
| Profit Before Tax | 3,632 | 3,385 | 2,390 | 52.0% | 7.3% |
| Tax Expenses | 1,055 | 709 | 564 | ||
| Reported Profit After Tax | 2,577 | 2,677 | 1,826 | 41.2% | -3.7% |
| EPS | 0.56 | 0.57 | 0.39 | 41.2% | -3.7% |
| Adjusted PAT | 3,069 | 3,229 | 2,398 | 28.0% | -5.0% |
| Adjusted PAT % | 15.2% | 16.4% | 15.3% | ||
| Adjusted EPS(₹) | 0.66 | 0.69 | 0.51 | 28.0% | -5.0% |
*Employee benefits expense excludes M&A earnout and SAR (shown separately under adjustments).
^ Other expenses exclude forex loss. ^^ Other income excludes forex gain. Forex Gain and Forex Loss clubbed together and shown separately.
** Adjusted EBITDA represents EBITDA adjusted for earnouts payable under the acquisition agreements (DCI, BirchAI & BroadPath), share-based payment awards and exclude other income (including forex gain/loss.
| FY26 | FY25 | YoY% |
|---|---|---|
| 71,929 | 55,699 | 29.1% |
| 44,506 | 33,283 | |
| 9,223 | 7,731 | |
| 18,200 | 14,685 | 23.9% |
| 25.3% | 26.4% | |
| 475 | 571 | |
| 122 | 1,134 | |
| 281 | 386 | |
| 698 | 177 | |
| 18,583 | 13,542 | 37.2% |
| 992 | 1,271 | |
| 4,874 | 4,669 | |
| 12,717 | 7,602 | 67.3% |
| 328 | ||
| 12,389 | 7,602 | 63.0% |
| 3,141 | 2,211 | |
| 9,248 | 5,391 | 71.5% |
| 1.98 | 1.17 | 69.2% |
| 11,306 | 8,107 | 39.5% |
| 15.7% | 14.6% | |
| 2.42 | 1.76 | 37.6% |
New Labor Code in India effective 21Nov 2025:
- Prescribes uniform definition of wages based on which employee benefits like gratuity, leave encashment & statutory bonus are computed.
- Past service costs of INR 294.7M towards Gratuity and INR 33.5M towards Compensated absence reported as exceptional items in Q3.
- Ongoing impact on overall Margins is likely to be 0.2% of Revenues.
sagility
Adjustments on EBITDA and PAT
Adj EBITDA Bridge: Q4 FY26 (₹M)
Adj PAT Bridge: Q4 FY26 (₹M)
Adj EBITDA Bridge: FY26 (₹M)
Adj PAT Bridge: FY26 (₹M)
Adj A - Earnouts under acquisition agreements and for PAT it is adjusted for tax
Adj B - Share based payment awards (non-cash expenses for the company and not tax deductible)
Adj C - Amortization of intangible assets (net of tax) that got created due to carveout of healthcare business from HGS
Adj D- Exceptional items for Q3 FY26 represents adjustment for labour codes (net of deferred tax) on account of increase in gratuity liability arising out of past service cost and increase in leave liability
adj20190105
sagility
Amt in ℓ M
Go Forward Positions
| Particulars | FY25 | FY26 | FY27 | FY28 | FY29 | FY30 |
|---|---|---|---|---|---|---|
| Closing Debt position | 8,020 | 5,670 | - | - | - | - |
| Debt Repayment | 2,490 | 2,350 | 5,670 | - | - | - |
| Interest Payment | 751 | 543 | 287 | - | - | - |
| Share based Payment awards | 1,134 | 122 | 138 | 72 | 37 | - |
| Earnouts Cost - DCI / Birch/ BroadPath | 571 | 475 | 6 | - | - | - |
| Intangibles Amortisation (A) | 1,400 | 1,462 | 1,562 | 1,562 | 1,562 | 1,562 |
| Intangibles Amortisation (B) | 188 | 392 | 408 | 392 | 312 | 265 |
Debt to be fully repaid by FY27.
Intangibles Amortisation (A) - Amortization of intangible assets that got created due to carveout of healthcare business from HGS
Intangibles Amortisation (B) - Amortisation for intangible assets acquired in relation to acquisitions (DCI, Birch and BroadPath) – Ends by FY33
s
sagility
Amt in ℓ M
Balance Sheet – 31st March 26
| Particulars | Mar 26 | Mar 25 |
|---|---|---|
| Property, plant and equipment | 4,624 | 3,699 |
| Right-of-use assets | 4,868 | 5,521 |
| Goodwill | 64,051 | 60,390 |
| Other intangible assets | 20,407 | 20,362 |
| Trade receivables and unbilled | 18,390 | 12,668 |
| Cash and cash equivalents (including investments) | 9,038 | 3,438 |
| Deferred tax assets (net) | 1,514 | 1,337 |
| Other Assets | 3,114 | 3,091 |
| Total Assets | 126,011 | 110,507 |
| Equity | 96,591 | 83,361 |
| Borrowings | 5,776 | 8,170 |
| Lease liabilities | 5,330 | 5,850 |
| Trade payables | 2,217 | 2,136 |
| Deferred tax liabilities (net) | 4,211 | 4,279 |
| Other Liabilities | 11,887 | 6,712 |
| Total Liabilities | 126,011 | 110,507 |
sability
Cash Flow – FY26
Amt in ₹ M
| Particulars | FY26 | FY25 |
|---|---|---|
| Profit before tax for the period/ year | 12,389 | 7,602 |
| Adjustment for Non-Operating and Non-Cash items | 5,271 | 6,982 |
| Adjustment for working capital | (1,895) | (710) |
| Income taxes paid (net of refunds) | (3,735) | (1,734) |
| Net cash flows generated from operating activities (A) - OCF | 12,030 | 12,141 |
| Addition to Fixed Assets | (1,922) | (1,244) |
| Free Cash flow (FCF) | 10,108 | 10,896 |
| Cash paid for M&A | - | (4,825) |
| Pending Purchase consideration paid for healthcare business carveout | - | (3,756) |
| Investment in Mutual fund and Fixed Deposit | (5,370) | - |
| Others | 185 | 184 |
| Net cash flows (used in) investing activities (B) | (7,107) | (9,642) |
| Capital infused by promoter | - | 3,708 |
| Share Issue expense (paid)/ reimbursed | - | 72 |
| Repayment of Promoter borrowings (include Interest) | (2,937) | (4,567) |
| Repayment of lease liabilities (include Interest) | (1,843) | (1,774) |
| Dividend paid | (234) | - |
| Net cash flows (used in) financing activities (C) | (5,014) | (2,561) |
| Net increase/(decrease) in cash and cash equivalents (A+B+C) | (91) | (62) |
| Cash and cash equivalents at the beginning of the year/period | 3,438 | 3,441 |
| Effect of movement in exchange rates on cash and cash equivalents | 233 | 58 |
| Cash and cash equivalents at the end of the year/ period | 3,579 | 3,438 |
| Net cash flows generated from operating activities % (OCF on Reported EBITDA) | 64.7% | 89.7% |
| Free Cash flow % (FCF on Reported EBITDA) | 54.4% | 80.5% |
s
sagility
Thank you.
in X f ☐
Copyright © 2026 Sagility. All rights reserved.